<?xml version="1.0" encoding="UTF-8"?>
<ref id="msw217-B31">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Iwuji</surname>
    <given-names>CC</given-names>
   </name>
   <name name-style="western">
    <surname>Orne-Gliemann</surname>
    <given-names>J</given-names>
   </name>
   <name name-style="western">
    <surname>Tanser</surname>
    <given-names>F</given-names>
   </name>
   <name name-style="western">
    <surname>Boyer</surname>
    <given-names>S</given-names>
   </name>
   <name name-style="western">
    <surname>Lessells</surname>
    <given-names>RJ</given-names>
   </name>
   <name name-style="western">
    <surname>Lert</surname>
    <given-names>F</given-names>
   </name>
   <name name-style="western">
    <surname>Imrie</surname>
    <given-names>J</given-names>
   </name>
   <name name-style="western">
    <surname>Barnighausen</surname>
    <given-names>T</given-names>
   </name>
   <name name-style="western">
    <surname>Rekacewicz</surname>
    <given-names>C</given-names>
   </name>
   <name name-style="western">
    <surname>Bazin</surname>
    <given-names>B</given-names>
   </name>
  </person-group>, 
  <etal/>
  <year>2013</year>
  <article-title>Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial</article-title>. 
  <source>Trials</source>
  <volume>14</volume>:
  <fpage>230.</fpage>
  <pub-id pub-id-type="pmid">23880306</pub-id>
 </mixed-citation>
</ref>
